tipifarnib has been researched along with lanosterol in 1 studies
Studies (tipifarnib) | Trials (tipifarnib) | Recent Studies (post-2010) (tipifarnib) | Studies (lanosterol) | Trials (lanosterol) | Recent Studies (post-2010) (lanosterol) |
---|---|---|---|---|---|
309 | 92 | 94 | 1,010 | 8 | 335 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buckner, FS; Gelb, MH; Hucke, O; Verlinde, CL | 1 |
1 other study(ies) available for tipifarnib and lanosterol
Article | Year |
---|---|
The protein farnesyltransferase inhibitor Tipifarnib as a new lead for the development of drugs against Chagas disease.
Topics: Alkyl and Aryl Transferases; Animals; Binding Sites; Chagas Disease; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Humans; Lanosterol; Models, Molecular; Oxidoreductases; Protein Binding; Quinolones; Sterol 14-Demethylase; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma cruzi | 2005 |